GB201609770D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB201609770D0
GB201609770D0 GBGB1609770.1A GB201609770A GB201609770D0 GB 201609770 D0 GB201609770 D0 GB 201609770D0 GB 201609770 A GB201609770 A GB 201609770A GB 201609770 D0 GB201609770 D0 GB 201609770D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1609770.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nucana PLC
Original Assignee
Nucana Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucana Biomed Ltd filed Critical Nucana Biomed Ltd
Priority to GBGB1609770.1A priority Critical patent/GB201609770D0/en
Publication of GB201609770D0 publication Critical patent/GB201609770D0/en
Priority to LTEP16820005.3T priority patent/LT3393478T/en
Priority to CA3008749A priority patent/CA3008749C/en
Priority to MYPI2018001015A priority patent/MY194629A/en
Priority to PCT/GB2016/054018 priority patent/WO2017109486A1/en
Priority to PT168200053T priority patent/PT3393478T/en
Priority to BR112018012956-9A priority patent/BR112018012956B1/en
Priority to EP16820005.3A priority patent/EP3393478B1/en
Priority to KR1020187020533A priority patent/KR20180096698A/en
Priority to MDE20181039T priority patent/MD3393478T2/en
Priority to SI201630680T priority patent/SI3393478T1/en
Priority to PL16820005T priority patent/PL3393478T3/en
Priority to JP2018532746A priority patent/JP6898329B2/en
Priority to CN201680082464.9A priority patent/CN108697725A/en
Priority to MEP-2020-56A priority patent/ME03677B/en
Priority to US16/065,498 priority patent/US20190022117A1/en
Priority to MA051576A priority patent/MA51576A/en
Priority to HUE16820005A priority patent/HUE050290T2/en
Priority to EA201891473A priority patent/EA037459B1/en
Priority to DK16820005.3T priority patent/DK3393478T3/en
Priority to SG11201805184TA priority patent/SG11201805184TA/en
Priority to AU2016375861A priority patent/AU2016375861B2/en
Priority to ES16820005T priority patent/ES2778933T3/en
Priority to MX2018007772A priority patent/MX2018007772A/en
Priority to EP20160070.7A priority patent/EP3738595A1/en
Priority to RS20200297A priority patent/RS60211B1/en
Priority to IL260076A priority patent/IL260076A/en
Priority to ZA2018/04155A priority patent/ZA201804155B/en
Priority to PH12018501339A priority patent/PH12018501339A1/en
Priority to HK18114265.9A priority patent/HK1255110A1/en
Priority to HRP20200423TT priority patent/HRP20200423T1/en
Priority to CY20201100245T priority patent/CY1122835T1/en
Priority to US17/845,878 priority patent/US20230149436A1/en
Ceased legal-status Critical Current

Links

GBGB1609770.1A 2015-12-23 2016-06-03 Combination therapy Ceased GB201609770D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GBGB1609770.1A GB201609770D0 (en) 2016-06-03 2016-06-03 Combination therapy
RS20200297A RS60211B1 (en) 2015-12-23 2016-12-21 Combination therapy
MA051576A MA51576A (en) 2015-12-23 2016-12-21 POLYTHERAPY
EA201891473A EA037459B1 (en) 2015-12-23 2016-12-21 Combination therapy
MYPI2018001015A MY194629A (en) 2015-12-23 2016-12-21 Combination therapy
HUE16820005A HUE050290T2 (en) 2015-12-23 2016-12-21 Combination therapy
PT168200053T PT3393478T (en) 2015-12-23 2016-12-21 Combination therapy
BR112018012956-9A BR112018012956B1 (en) 2015-12-23 2016-12-21 USE OF GENCITABINE-[PHENYL-(BENZOXY-L-ALANYNYL)]-PHOSPHATE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF IN THE TREATMENT OF CANCER
EP16820005.3A EP3393478B1 (en) 2015-12-23 2016-12-21 Combination therapy
CA3008749A CA3008749C (en) 2015-12-23 2016-12-21 Treatment of ovarian cancer or biliary tract cancer with a combination of gemcitabine-(phenyl-benzoxy-l-alaninyl)]-phosphate and cisplatin
MDE20181039T MD3393478T2 (en) 2015-12-23 2016-12-21 Combination therapy
SI201630680T SI3393478T1 (en) 2015-12-23 2016-12-21 Combination therapy
PL16820005T PL3393478T3 (en) 2015-12-23 2016-12-21 Combination therapy
JP2018532746A JP6898329B2 (en) 2015-12-23 2016-12-21 Combination therapy
CN201680082464.9A CN108697725A (en) 2015-12-23 2016-12-21 Combination treatment
DK16820005.3T DK3393478T3 (en) 2015-12-23 2016-12-21 combination therapy
US16/065,498 US20190022117A1 (en) 2015-12-23 2016-12-21 Combination therapy
LTEP16820005.3T LT3393478T (en) 2015-12-23 2016-12-21 Combination therapy
PCT/GB2016/054018 WO2017109486A1 (en) 2015-12-23 2016-12-21 Combination therapy
KR1020187020533A KR20180096698A (en) 2015-12-23 2016-12-21 Combination therapy
MEP-2020-56A ME03677B (en) 2015-12-23 2016-12-21 Combination therapy
SG11201805184TA SG11201805184TA (en) 2015-12-23 2016-12-21 Combination therapy
AU2016375861A AU2016375861B2 (en) 2015-12-23 2016-12-21 Combination therapy
ES16820005T ES2778933T3 (en) 2015-12-23 2016-12-21 Combination therapy
MX2018007772A MX2018007772A (en) 2015-12-23 2016-12-21 Combination therapy.
EP20160070.7A EP3738595A1 (en) 2015-12-23 2016-12-21 Combination therapy
IL260076A IL260076A (en) 2015-12-23 2018-06-17 Combination therapy
ZA2018/04155A ZA201804155B (en) 2015-12-23 2018-06-21 Combination therapy
PH12018501339A PH12018501339A1 (en) 2015-12-23 2018-06-21 Combination therapy
HK18114265.9A HK1255110A1 (en) 2015-12-23 2018-11-08 Combination therapy
HRP20200423TT HRP20200423T1 (en) 2015-12-23 2020-03-16 Combination therapy
CY20201100245T CY1122835T1 (en) 2015-12-23 2020-03-17 COMBINED THERAPY
US17/845,878 US20230149436A1 (en) 2015-12-23 2022-06-21 Combination therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1609770.1A GB201609770D0 (en) 2016-06-03 2016-06-03 Combination therapy

Publications (1)

Publication Number Publication Date
GB201609770D0 true GB201609770D0 (en) 2016-07-20

Family

ID=56508059

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1609770.1A Ceased GB201609770D0 (en) 2015-12-23 2016-06-03 Combination therapy

Country Status (1)

Country Link
GB (1) GB201609770D0 (en)

Similar Documents

Publication Publication Date Title
IL263521A (en) Combination therapy
IL257976A (en) Combination therapy
GB201516442D0 (en) Combination therapy
IL265406B (en) Combination therapy
HK1255110A1 (en) Combination therapy
GB201609597D0 (en) Therapy
GB201604318D0 (en) Combination therapy
GB201604316D0 (en) Combination therapy
IL265340A (en) Combination therapy
GB201609735D0 (en) Combination therapy
GB201603653D0 (en) Combination Therapy
GB201618477D0 (en) Therapy
GB201613179D0 (en) Combination therapy
GB201706227D0 (en) Combination therapy
GB201706221D0 (en) Combination therapy
GB201706222D0 (en) Combination therapy
GB201706223D0 (en) Combination therapy
GB201706224D0 (en) Combination therapy
GB201706225D0 (en) Combination therapy
GB201706226D0 (en) Combination therapy
GB201706228D0 (en) Combination therapy
GB201706229D0 (en) Combination therapy
GB201704279D0 (en) Combination therapy
GB201704281D0 (en) Combination therapy
GB201704286D0 (en) Combination Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)